Rafina Innovations Inc.
$0.00+0.00%(+$0.00)
TickerSpark Score
60/100
87
Valuation
40
Profitability
15
Growth
60
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VICA research report →
52-Week Range82% of range
Low $0.00
Current $0.00
High $0.00
Companyrafina-innovations.com
Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology.
- CEO
- Nikolaos Kardaras
- IPO
- 2013
- Employees
- 4
- HQ
- Glasgow, GB
Price Chart
+900.00% · this period
Valuation
- Market Cap
- $14.57K
- P/E
- -0.09
- P/S
- 0.00
- P/B
- 0.02
- EV/EBITDA
- -0.39
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -5.17%
- Op Margin
- -26.61%
- Net Margin
- -26.95%
- ROE
- -55.48%
- ROIC
- -19.64%
Growth & Income
- Revenue
- $3.26M · 0.00%
- Net Income
- $-879,207 · -934.63%
- EPS
- $-0.01 · -226.47%
- Op Income
- $-868,250
- FCF YoY
- -2163.27%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 6.74
- Avg Volume
- 104.25K
Get TickerSpark's AI analysis on VICA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 20, 18 | Zertalis Constantinos | buy | 3,000 |
| Jul 13, 18 | Zertalis Constantinos | buy | 700 |
| Jun 28, 18 | Zertalis Constantinos | buy | 500 |
| Jun 28, 18 | Zertalis Constantinos | buy | 173,363 |
| Jun 27, 18 | Zertalis Constantinos | buy | 500 |
| Jun 25, 18 | Zertalis Constantinos | buy | 1,000 |
| Jun 20, 18 | Zertalis Constantinos | buy | 3,000 |
| Jun 15, 18 | Zertalis Constantinos | buy | 5,000 |
| Jun 15, 18 | Zertalis Constantinos | buy | 6,000 |
| Jun 15, 18 | Zertalis Constantinos | buy | 3,000 |
Our VICA Coverage
We haven't published any research on VICA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate VICA Report →Similar Companies
VIVE+0.00%
Viveve Medical, Inc.
$0.00
NMRD+0.00%
Nemaura Medical Inc.
$0.00
LCDX+0.00%
Caliber Imaging & Diagnostics, Inc.
$0.00
REMI+0.00%
Remedent, Inc.
$0.00
BXRXQ+0.00%
Baudax Bio, Inc.
$0.00
STBV+0.00%
Strategic Global Investments, Inc.
$0.00
EMGE+0.00%
Emergent Health Corp
$0.00
CYPS+0.00%
Cyclo3pss Corporation
$0.00